🇺🇸 FDA
Pipeline program

Placebo

PTG-300-11

Phase 3 small_molecule active

Quick answer

Placebo for Polycythemia Vera is a Phase 3 program (small_molecule) at Protagonist Therapeutics, Inc with 1 ClinicalTrials.gov record(s).

Program details

Company
Protagonist Therapeutics, Inc
Indication
Polycythemia Vera
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials